Annual Report 2012-2013 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2012-2013. During the financial year, The Company’s Total Income Rs. 26,683 million. Net Profit after Tax for the year Rs. 5,166 million. This includes an element of one time sales of Rs. 1.8 billion in the fourth quarter. The dividend on Equity shares Rs. 5,178. Book value per equity share of Rs.1/- each Rs. 75/-. The Company on 3^rd August 2013 allotted 1,035,581,955 Equity Shares of Rs.1/- each as Bonus Shares to the Equity Shareholders of the Company in the ratio of 1 (One) Equity Share of Rs.1/- each for every 1(One) Equity Share of Rs.1/- each held on the Record Date, 30^th July 2013.

The Board of Directors has recommended an equity dividend of Rs. 2.50 per equity share of face value Rs. 1/- each (equivalent to Rs. 5.00 per equity share pre-bonus) (previous year Rs. 4.25 per equity share) for the year ended 31^st March 2013.

More Annual Report of Sun Pharmaceutical Industries Limited: